Dedicare Logo

Dedicare

European recruitment and staffing firm for healthcare, life science, and social work sectors.

DEDI | ST

Overview

Corporate Details

ISIN(s):
SE0003909282 (+1 more)
LEI:
549300F01ELNT82H4P50
Country:
Sweden
Address:
Ringvägen 100, 118 60 Stockholm
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Dedicare is a leading European recruitment and staffing provider specializing in the healthcare, life science, and social work sectors. As the largest firm of its kind in the Nordic region, it connects qualified professionals with both temporary (locum) and permanent roles in healthcare organizations. The company operates globally, with a significant presence in the UK and Scandinavia. Dedicare offers comprehensive placement services, managing logistics like travel and accommodation, and providing professional support such as appraisals and revalidation. The firm focuses on precision, reliability, and building long-term partnerships with both clients and candidates. In the UK, the company unified its brand from Templars Medical to Dedicare in May 2023.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 08:00
Quarterly Report
Swedish 1.5 MB
2025-10-23 08:00
Quarterly Report
English 1.6 MB
2025-10-13 11:53
Major Shareholding Notification
Swedish 10.7 KB
2025-09-23 08:30
M&A Activity
Dedicare stärker sin position i Danmark: förvärvar WeCare ApS
Swedish 156.9 KB
2025-07-11 08:00
Interim Report
Swedish 1.4 MB
2025-07-11 08:00
Interim Report
English 1.5 MB
2025-04-24 20:00
Post-Annual General Meeting Information
Kommuniké från Dedicare AB (publ) årsstämma 2025
Swedish 53.2 KB
2025-04-24 15:00
Quarterly Report
Swedish 1.2 MB
2025-04-24 15:00
Quarterly Report
English 1.2 MB
2025-03-24 15:01
Annual Report (ESEF)
Swedish 20.7 MB
2025-03-24 15:01
Annual Report (ESEF)
Swedish 20.7 MB
2025-03-24 08:30
Pre-Annual General Meeting Information
Kallelse till årsstämma - Dedicare AB (Publ)
Swedish 168.5 KB
2025-02-07 08:00
Earnings Release
Swedish 1.1 MB
2025-02-07 08:00
Earnings Release
English 1.2 MB
2024-10-24 08:01
Quarterly Report
Swedish 1.5 MB

Automate Your Workflow. Get a real-time feed of all Dedicare filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Dedicare

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Dedicare via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-03-24 Kasper Madsen Other Sell 5,937 291,269.22 SEK
2025-03-21 Kasper Madsen Other Sell 10,766 528,287.62 SEK
2025-03-20 Kasper Madsen Other Sell 16,909 829,555.54 SEK
2025-03-19 Kasper Madsen Other Sell 11,578 569,058.70 SEK
2025-03-19 Kasper Madsen Other Sell 2,500 123,375.00 SEK
2025-03-18 Kasper Madsen Other Sell 1,451 71,911.56 SEK
2021-05-31 Krister Widström Other Other 60,000 295,200.00 SEK

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.